Iida N, Imai M, Okamoto W, Kato T, et al. Novel ERBB2 Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal Cancer. Clin Cancer Res 2024 Aug 20:OF1-OF12. doi: 10.1158/1078-0432.CCR-24-1023.
PMID: 39163021